Increased aneuploidy in Alzheimer disease

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Alzheimer disease is a leading cause of presenile dementia.
• The underlying cytogenetic mechanisms of Alzheimer disease remain incompletely understood.
• Investigating chromosomal abnormalities may offer insights into disease pathogenesis.

Purpose of the Study:

• To investigate the presence of cytogenetic changes, specifically aneuploidy, in Alzheimer disease.
• To compare aneuploidy rates in sporadic and familial Alzheimer disease cases with unaffected controls.
• To explore the potential of aneuploidy as a predictive biomarker for Alzheimer disease.

Main Methods:

• Chromosome analysis using GTG banding was performed on 100 cells per individual.
• Three groups were studied: sporadic Alzheimer disease (8 cases), familial Alzheimer disease (5 cases), and unaffected siblings (9 cases).
• Aneuploidy rates were statistically compared against age- and sex-matched controls.

Main Results:

• A significant increase in aneuploidy was observed in 5/8 sporadic Alzheimer disease patients (P < 0.05).
• All 5 familial Alzheimer disease patients showed a statistically significant increase in aneuploidy (P < 0.001).
• Two unaffected siblings also exhibited significantly elevated aneuploidy, suggesting potential predictive value.

Conclusions:

• Cytogenetic changes, particularly aneuploidy, are prevalent in Alzheimer disease.
• Increased aneuploidy may serve as an early indicator or predictor of Alzheimer disease.
• Further research is warranted to validate aneuploidy as a biomarker for Alzheimer disease risk.